Geode Capital Management
SPRB icon

Geode Capital Management’s Spruce Biosciences SPRB Stock Holding History

Geode Capital Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.24M Sell
66,757
-3,791
-5% -$192K ﹤0.01% 3036
2026
Q2 		$3.81M Buy
70,548
+57,659
+447% +$3.22M ﹤0.01% 3027
2026
Q1 		$843K Buy
12,889
+157
+1% +$10.8K ﹤0.01% 3412
2025
Q4 		$1.11M Buy
+12,732
New +$1.36M ﹤0.01% 3343
2025
Q2 		– Sell
-3,689
Closed -$80.3K – 4551
2025
Q1 		$80.3K Buy
3,689
+39
+1% +$1.09K ﹤0.01% 4090
2024
Q4 		$115K Buy
3,650
+157
+4% +$5.76K ﹤0.01% 4063
2024
Q3 		$124K Buy
3,493
+773
+28% +$28.3K ﹤0.01% 4040
2024
Q2 		$106K Buy
2,720
+51
+2% +$2.73K ﹤0.01% 4124
2024
Q1 		$157K Buy
2,669
+437
+20% +$111K ﹤0.01% 4016
2023
Q4 		$491K Hold
2,232
– – ﹤0.01% 3619
2023
Q3 		$378K Sell
2,232
-673
-23% -$113K ﹤0.01% 3710
2023
Q2 		$469K Buy
2,905
+2,097
+260% +$351K ﹤0.01% 3671
2023
Q1 		$134K Hold
808
– – ﹤0.01% 4228
2022
Q4 		$66K Sell
808
-2
-0.2% -$167 ﹤0.01% 4517
2022
Q3 		$83K Hold
810
– – ﹤0.01% 4636
2022
Q2 		$105K Sell
810
-884
-52% -$113K ﹤0.01% 4574
2022
Q1 		$255K Sell
1,694
-206
-11% -$38.3K ﹤0.01% 4259
2021
Q4 		$635K Buy
1,900
+414
+28% +$123K ﹤0.01% 3925
2021
Q3 		$669K Sell
1,486
-228
-13% -$143K ﹤0.01% 3890
2021
Q2 		$1.44M Buy
1,714
+253
+17% +$270K ﹤0.01% 3422
2021
Q1 		$1.82M Sell
1,461
-106
-7% -$163K ﹤0.01% 3293
2020
Q4 		$2.86M Buy
+1,567
New +$2.6M ﹤0.01% 2887

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return
DMKJ
David M. Knott Jr $183M AUM 73.23% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Persistent Asset Partners
Persistent Asset Partners Hong Kong $362M AUM 191.92% 1-Year Est. Return

Geode Capital Management's SPRB Position: Q3 2026 in Review

Geode Capital Management reduced its Spruce Biosciences (SPRB) stake by 5.4% in Q3 2026, selling an estimated $192K and leaving 66,757 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3036.

Geode Capital Management first reported a position in SPRB in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.81M in Q2 2026. 42 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • Geode Capital Management held 66,757 shares of Spruce Biosciences worth $3.24M as of Q3 2026.
  • Geode Capital Management sold 3,791 Spruce Biosciences shares in Q3 2026, an estimated $192K.
  • Spruce Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3036 holding.
  • Geode Capital Management first reported a position in Spruce Biosciences in Q4 2020 and has held it in 22 quarters since.
  • Geode Capital Management's Spruce Biosciences position peaked at $3.81M in Q2 2026.
  • 42 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.